Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001424 · ClinicalTrials.gov registry record
Evaluation and Natural History of Children With Cancer and AIDS
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 110
- Enrollment target
NCT00001424: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001424 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001424 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 1994-11 |
| Est. Completion | 2000-08 |
What the finished NCT00001424 record still lists
NCT00001424 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001424 about?
NCT00001424 is a clinical study titled "Evaluation and Natural History of Children With Cancer and AIDS". Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.
What is the current status of trial NCT00001424?
This trial is currently completed. The enrollment target is 110 participants. The study started on 1994-11. Estimated completion is 2000-08.
Who is sponsoring clinical trial NCT00001424?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia